Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[New drug therapy for retinal degeneration].

Nippon Ganka Gakkai zasshi - 1 Jan 2008

Ohguro Hiroshi

Abstract excerpt

Retinitis pigmentosa (RP) is an inherited retinal degeneration characterized by nyctalopia, ring scotoma, and bone-spicule pigmentation of the retina. So far, no effective therapy has been found for RP. As a possible molecular etiology of RP, retina-specific gene deficits are most likely involved, but little has been identified in terms of intracellular mechanisms leading to retinal photoreceptor cell death at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium Channel Blockers
Share to Dark Adaptation
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Nifedipine

Share to Phosphorylation

Share to Retinitis Pigmentosa

Share to Rhodopsin

Source

Identifiers

PMID: 18240599

Genes

ERG
RPE

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[New drug therapy for retinal degeneration].PMID 18240599Read ↗

Inherited retinal degenerations: therapeutic prospects.Semantic proximity Read ↗

Retinitis Pigmentosa: From Pathomolecular Mechanisms to Therapeutic StrategiesSemantic proximity Read ↗

Mechanisms of Rhodopsin-Related Inherited Retinal Degeneration and Pharmacological Treatment Strategies.Semantic proximity Read ↗

Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical StrategiesSemantic proximity Read ↗

Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa.Semantic proximity Read ↗

Molecular mechanisms underlying inherited photoreceptor degeneration as targets for therapeutic interventionSemantic proximity Read ↗

Drug screening with zebrafish visual behavior identifies carvedilol as a potential treatment for an autosomal dominant form of retinitis pigmentosa.Semantic proximity Read ↗

The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: From Pathomolecular Mechanisms to the Development of Cell-Based TherapiesSemantic proximity Read ↗

Retinitis pigmentosaSemantic proximity Read ↗

[Cause of retinitis pigmentosa and new therapeutics under development].Semantic proximity Read ↗

Retinitis pigmentosa: understanding the clinical presentation, mechanisms and treatment optionsSemantic proximity Read ↗

Retinitis pigmentosa and stem cell therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.